CymaBay Therapeutics, Inc. CBAY

Full chart Compare
Set alert

Price alert · CBAY

All alert types
32.48 +32.48

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $30.39MGross Profit → Expenses: $30.39MRevenue → Cost of Revenue: $681.00KExpenses → Selling, General & Admin: $51.95MExpenses → Research & Development: $80.12MExpenses → Other Expenses: $3.69MNet Loss → Expenses: $105.37MGross Profit$30.39MNet Loss$105.37MCost of Revenue$681.00KExpenses$135.76MSelling, General & Admin$51.95MResearch & Development$80.12MOther Expenses$3.69MRevenue$31.07M

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

CBAY annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
31.07M0000
31.07M0000
31.07M0000
132.75M93.11M87.58M52.60M108.15M
80.80M68.00M64.54M35.88M83.84M
51.95M25.12M23.04M16.72M19.24M
-101.68M-93.11M-87.58M-52.60M-108.15M
18.95M14.91M2.58M00
-105.37M-106.00M-90.00M-50.99M-102.81M
-105.37M-106.00M-90.00M-50.99M-102.81M
-105.37M-106.00M-90.00M-50.99M-102.81M
-105.37M-106.00M-90.00M-50.99M-102.81M
-0.99-1.21-1.27-0.74-1.53
-0.99-1.21-1.27-0.74-1.53
-0.99-1.21-1.27-0.74-1.53
-86.42M-91.09M-87.42M-50.99M-102.81M
-86.42M-91.09M-87.42M-50.99M-102.81M
106.20M87.80M71.06M68.89M67.03M
106.20M87.80M71.06M68.89M67.03M